← Evidence map

ArticleOncology reports2023

Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma.

Liwei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36734286